Assets, Current of ARTELO BIOSCIENCES, INC. from 31 Aug 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
ARTELO BIOSCIENCES, INC. quarterly Assets, Current in USD history and change rate from 31 Aug 2014 to 31 Dec 2025.
  • ARTELO BIOSCIENCES, INC. Assets, Current for the quarter ending 31 Dec 2025 was $695,000, a 73% decline year-over-year.
Source SEC data
View on sec.gov
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Change (%)

ARTELO BIOSCIENCES, INC. Quarterly Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $695,000 -$1,862,000 -73% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $1,827,000 -$3,159,000 -63% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $2,233,000 -$3,935,000 -64% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $1,382,000 -$6,806,000 -83% 31 Mar 2025 8-K 11 Jul 2025
Q4 2024 $2,557,000 -$8,423,000 -77% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $4,986,000 -$8,442,000 -63% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $6,168,000 -$8,434,000 -58% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $8,188,000 -$8,198,000 -50% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $10,980,000 -$7,342,000 -40% 31 Dec 2023 8-K 11 Jul 2025
Q3 2023 $13,428,000 -$6,875,000 -34% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $14,602,000 -$7,680,000 -34% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $16,386,000 -$8,203,000 -33% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $18,322,000 -$6,287,000 -26% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 $20,303,000 +$9,986,000 +97% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $22,282,000 +$11,981,717 +116% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $24,589,000 +$13,183,804 +116% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $24,609,000 +$17,109,259 +228% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $10,317,000 +$7,980,000 +341% 31 Aug 2021 10-K 31 Mar 2023 2022 FY
Q2 2021 $10,300,283 +$8,847,657 +609% 31 May 2021 10-Q 12 Jul 2021 2021 Q3
Q1 2021 $11,405,196 +$9,294,185 +440% 28 Feb 2021 10-Q 13 Apr 2021 2021 Q2
Q4 2020 $7,499,741 +$3,991,838 +114% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 $2,337,000 -$2,105,588 -47% 31 Aug 2020 10-KT 21 Mar 2022 2022 Q1
Q2 2020 $1,452,626 +$300,231 +26% 31 May 2020 10-Q 13 Jul 2020 2020 Q3
Q1 2020 $2,111,011 +$1,627,143 +336% 29 Feb 2020 10-Q 13 Apr 2020 2020 Q2
Q4 2019 $3,507,903 +$3,343,021 +2028% 30 Nov 2019 10-Q 14 Jan 2020 2020 Q1
Q3 2019 $4,442,588 +$4,046,153 +1021% 31 Aug 2019 10-K 04 Nov 2020 2020 FY
Q2 2019 $1,152,395 +$752,050 +188% 31 May 2019 10-Q 15 Jul 2019 2019 Q3
Q1 2019 $483,868 -$56,489 -10% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 $164,882 -$264,610 -62% 30 Nov 2018 10-Q 14 Jan 2019 2019 Q1
Q3 2018 $396,435 -$177,840 -31% 31 Aug 2018 10-K/A 18 Dec 2019 2019 FY
Q2 2018 $400,345 +$172,507 +76% 31 May 2018 10-Q 13 Jul 2018 2018 Q3
Q1 2018 $540,357 +$526,900 +3915% 28 Feb 2018 10-Q/A 14 May 2018 2018 Q2
Q4 2017 $429,492 +$425,902 30 Nov 2017 10-Q/A 21 Mar 2018 2018 Q1
Q3 2017 $574,275 +$570,685 31 Aug 2017 10-K 29 Nov 2018 2018 FY
Q2 2017 $227,838 +$224,248 31 May 2017 10-Q 21 Jul 2017 2017 Q3
Q1 2017 $13,457 +$9,867 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 $3,590* -$381 30 Nov 2016 10-Q 10 Jan 2017 2017 Q1
Q3 2016 $3,590* -$13,439 31 Aug 2016 10-K 29 Nov 2017 2017 FY
Q2 2016 $3,590* -$8,991 31 May 2016 10-Q 05 Jul 2016 2016 Q3
Q1 2016 $3,590* -$4,491 29 Feb 2016 10-Q 01 Apr 2016 2016 Q2
Q4 2015 $3,971 30 Nov 2015 10-Q 14 Jan 2016 2016 Q1
Q3 2015 $17,029 +$2,298 +16% 31 Aug 2015 10-K 29 Nov 2016 2016 FY
Q2 2015 $12,581 31 May 2015 10-Q 15 Jul 2015 2015 Q3
Q1 2015 $8,081 28 Feb 2015 10-Q 14 Apr 2015 2015 Q2
Q3 2014 $14,731 31 Aug 2014 10-K 11 Dec 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.